Division of Experimental Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
PLoS One. 2007 Jul 25;2(7):e641. doi: 10.1371/journal.pone.0000641.
Characterization of intrinsic and extrinsic factors regulating the self-renewal/division and differentiation of stem cells is crucial in determining embryonic stem (ES) cell fate. ES cells differentiate into multiple hematopoietic lineages during embryoid body (EB) formation in vitro, which provides an experimental platform to define the molecular mechanisms controlling germ layer fate determination and tissue formation.
The cannabinoid receptor type 1 (CB1) and cannabinoid receptor type 2 (CB2) are members of the G-protein coupled receptor (GPCR) family, that are activated by endogenous ligands, the endocannabinoids. CB1 receptor expression is abundant in brain while CB2 receptors are mostly expressed in hematopoietic cells. However, the expression and the precise roles of CB1 and CB2 and their cognate ligands in ES cells are not known. We observed significant induction of CB1 and CB2 cannabinoid receptors during the hematopoietic differentiation of murine ES (mES)-derived embryoid bodies. Furthermore, mES cells as well as ES-derived embryoid bodies at days 7 and 14, expressed endocannabinoids, the ligands for both CB1 and CB2. The CB1 and CB2 antagonists (AM251 and AM630, respectively) induced mES cell death, strongly suggesting that endocannabinoids are involved in the survival of mES cells. Treatment of mES cells with the exogenous cannabinoid ligand Delta(9)-THC resulted in the increased hematopoietic differentiation of mES cells, while addition of AM251 or AM630 blocked embryoid body formation derived from the mES cells. In addition, cannabinoid agonists induced the chemotaxis of ES-derived embryoid bodies, which was specifically inhibited by the CB1 and CB2 antagonists.
This work has not been addressed previously and yields new information on the function of cannabinoid receptors, CB1 and CB2, as components of a novel pathway regulating murine ES cell differentiation. This study provides insights into cannabinoid system involvement in ES cell survival and hematopoietic differentiation.
鉴定调控干细胞自我更新/分裂和分化的内在和外在因素对于确定胚胎干细胞(ES)细胞命运至关重要。ES 细胞在体外胚状体(EB)形成过程中分化为多种造血谱系,这为定义控制胚层命运决定和组织形成的分子机制提供了一个实验平台。
大麻素受体 1 型(CB1)和大麻素受体 2 型(CB2)是 G 蛋白偶联受体(GPCR)家族的成员,它们被内源性配体内源性大麻素激活。CB1 受体在大脑中表达丰富,而 CB2 受体主要在造血细胞中表达。然而,CB1 和 CB2 及其同源配体在 ES 细胞中的表达和确切作用尚不清楚。我们观察到在鼠源性 ES(mES)衍生的胚状体造血分化过程中 CB1 和 CB2 大麻素受体的显著诱导。此外,mES 细胞以及第 7 天和第 14 天的 ES 衍生胚状体表达内源性大麻素,即 CB1 和 CB2 的配体。CB1 和 CB2 拮抗剂(分别为 AM251 和 AM630)诱导 mES 细胞死亡,强烈表明内源性大麻素参与 mES 细胞的存活。用外源性大麻素配体 Delta(9)-THC 处理 mES 细胞导致 mES 细胞造血分化增加,而添加 AM251 或 AM630 则阻断 mES 细胞来源的胚状体形成。此外,大麻素激动剂诱导 ES 衍生胚状体的趋化性,这可被 CB1 和 CB2 拮抗剂特异性抑制。
这项工作以前没有被涉及,提供了关于大麻素受体 CB1 和 CB2 作为调节鼠源性 ES 细胞分化的新途径的组成部分的功能的新信息。本研究深入了解大麻素系统在 ES 细胞存活和造血分化中的作用。